Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CoinEx’s Strategic Evolution: A “Dark Horse” in the 2024 Crypto Bull Market
-
CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes
-
APA Corporation Announces Results of Private Exchange Offers, Tender Offers, and Consent Solicitations at Extended Early Consent Date and Upsizing of Tender Offers
-
SPX Technologies Announces Agreement to Purchase Kranze Technology Solutions (“KTS”)
-
Replimune to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Neutrolis Licenses University of Illinois Chicago Patent to Advance Topical Dry Eye Disease Therapy Targeting NETs
-
NV5 Awarded $5 Million Bypass Project by Georgia Department of Transportation
-
Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia
-
Concrete Pumping Holdings Sets Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Thursday, January 9, 2025
-
Cerence Announces Repurchase of $27 Million of 3% Senior Notes Due 2025
-
E Ink Earns Spot on DJSI World and Emerging Markets Indices for the Third Consecutive Year
-
Psyence Biomed Announces $2.0 Million Private Placement
-
AgEagle Aerial Systems Highlights Historic Sales Achievements and New Strategic Vision in 2024
-
Giftify, Inc. Cancels Registered Direct Offering
-
White Gold Corp. Closes $5M First Tranche of Upsized Private Placement
-
iLearningEngines Voluntarily Initiates Chapter 11 Proceedings
-
Vivos Therapeutics Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Swvl to Provide Last-Mile Shuttle Services for SAB Bank Following Riyadh Metro Launch
-
authID Joins the Accountable Digital Identity Association to Drive Reusable Identities Across the Internet
-
American Hotel Income Properties REIT LP Announces Normal Course Issuer Bid and Automatic Securities Purchase Plan
-
Signati™ Medical Successfully Completes IDE Trial for Separo™ Vessel Sealing System and Initiates FDA Market Clearance Process
-
AI Exit: Aporia Acquired by Coralogix
-
Getty Realty Corp. to Report Fourth Quarter 2024 Financial Results
-
LGI Homes Celebrates Major Milestone with 75,000th Home Closing
-
ELFA CapEx Finance Index Reveals Durable Goods Orders Poised for 0.12% Growth in November
-
Spectral AI Announces Confirmation of Compliance of its Nasdaq Listing Requirements
-
Concrete Pumping Holdings Sets Fourth Quarter and Fiscal Year 2024 Earnings Conference Call for Thursday, January 9, 2025
-
Orezone Gold Corporation issues Amended Convertible Debenture to Resource Capital Fund VII L.P.
-
Fly-E Group, Inc. Selected as the Official E-Bike Provider for NYC DOT’s Trade-In Program
-
PayPoint plc : Director/PDMR Shareholding
-
FibroBiologics Announces $25 Million Financing
-
Scatec awarded 288 MW Solar PV in government tender in South Africa
-
Alliance Witan PLC - Net Asset Value
-
Unveiling CoinEx: The Unexpected Powerhouse of the Crypto Boom
-
Rectitude Secures Initial Sales Contracts for Innovative New Energy Solutions, Entering the Multi-Billion-Dollar Green Energy Market in Southeast Asia
-
COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization
-
Osisko Announces Acquisition of Additional Gibraltar Silver Stream Interest and Closing of the Dalgaranga Royalties Acquisition
-
Intetics Introduces a Cutting-Edge Mobile App for Real-Time Cardiac Monitoring
-
TC Energy provides results of Series 1 and Series 2 conversion elections
-
FlexShopper Announces First Come First Serve Extension of Rights Offering
-
Saputo Inc. Announces a Change in Senior Management
-
Aveanna to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
-
Matador Adds Bitcoin to its Balance Sheet
-
NextGen Digital Announces Listing on Frankfurt Stock Exchange
-
VYNE Therapeutics Reports Positive Top-line Phase 1a MAD Data for VYN202, its Novel BD2-Selective BET Inhibitor
-
Psyence Biomedical Regains Full Compliance with All Nasdaq Continued Listing Requirements
-
Comstock Fuels and Emerging Fuels Technology Advance SAF and Other Renewable Fuel Yields
-
Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
-
Cingulate Completes Financing Transaction for Net Proceeds of $5,000,000
